News

News Archive

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076, currently in Phase I clinical development

Today announced the publication of the results of a non-clinical study describing the characterization of the anti-CD205 Antibody-Drug Conjugate (ADC) MEN1309/OBT076

Menarini Ricerche at the 24th EHA congress presenting the First In Human clinical study of SEL24/MEN1703

Menarini Ricerche at the 24th EHA congress presenting the First In Human clinical study of SEL24/MEN1703

Acute Myeloid Leukemia: Menarini Ricerche will present the First In Human clinical trial of SEL24/MEN1703

Acute Myeloid Leukemia will present at the 24th EHA Congress 2019 in Amsterdam on the First In Human clinical trial of SEL24/MEN1703 (DIAMOND-01, NCT03008187)

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More